000 | 00852 a2200253 4500 | ||
---|---|---|---|
005 | 20250512013415.0 | ||
264 | 0 | _c19900125 | |
008 | 199001s 0 0 eng d | ||
022 | _a0190-535X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aParkinson, D R | |
245 | 0 | 0 |
_aThe role of interleukin-2 in the biotherapy of cancer. _h[electronic resource] |
260 |
_bOncology nursing forum _c |
||
300 |
_a16-20 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Review | ||
650 | 0 | 4 |
_aCarcinoma, Renal Cell _xtherapy |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-2 _xadverse effects |
650 | 0 | 4 |
_aKidney Neoplasms _xtherapy |
650 | 0 | 4 | _aKiller Cells, Lymphokine-Activated |
650 | 0 | 4 |
_aMelanoma _xtherapy |
773 | 0 |
_tOncology nursing forum _gvol. 16 _gno. 6 Suppl _gp. 16-20 |
|
999 |
_c2693690 _d2693690 |